Clinical Trial

A Study to Investigate Canvuparatide Compared With Placebo in Adult Patients With Hypoparathyroidism

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The purpose of this study is to investigate the efficacy and safety of canvuparatide administered as a once-weekly (QW) treatment to adult study participants with hypoparathyroidism (HypoPT).
Trial Details
NCT Number NCT07699471
Lead Sponsor MBX Biosciences
Conditions Hypoparathyroidism
Enrollment 160 participants
Start Date 2026-08
Primary Completion 2028-01 (estimated)
Study Completion 2029-08 (estimated)
Updated on ClinicalTrials.gov 2026-07-13